Introduction. To date sacrocolpopexy is regarded as the reference standard treatment for primarily apical compartment prolapse and multicompartment prolapse. Most bladder and bowel dysfunction improves postoperatively after sacrocolpopexy; however, de novo bowel or de novo bladder dysfunction can occur. The inferior hypogastric nerve is commonly known among pelvic surgeons. However, the inferior hypogastric nerve and its fine fibers are difficult to identify; iatrogenic lesion is commonly tolerated although this can lead to bladder, bowel and sexual dysfunction. This study was performed to assess the functional outcome after nerve-sparing sacrocolpopexy. Material and methods. From 2014 to 2016 all women undergoing a laparoscopic sacrocolpopexy for apical or multicompartment prolapse stage >2 were included in this prospective study. Laparoscopic sacrocolpopexy was performed using the nerve-sparing approach. Objective outcome was assessed by preoperative and postoperative POP-Q changes. De novo bladder and de novo bowel dysfunction were subjectively and objectively evaluated. Results. In all, 137 women were included. Significant objective improvement for point Aa and C (p < 0.0001) preoperatively to postoperatively was seen. The posterior compartment remained unchanged with point Ba À2. De novo overactive bladder and de novo bladder outlet obstruction with elevated postresidual volume were seen for both in 0.7% (1/137). De novo stress urinary incontinence was seen in 0.7% (5/137). De novo constipation was seen in 5%, bowel incontinence in 0% and resolution of pre-existing obstipation in 14.5%. De novo laxative use (9%) in the first 12 weeks was the most common postoperative problem. Conclusion. We could demonstrate that when a nervesparing technique is applied for sacrocolpopexy low de novo bladder (18%) and de novo bowel dysfunction can be seen.
Introduction
Pelvic organ prolapse (POP) is a common condition that affects older women (1) and can impair bladder, bowel and sexual function. To date, sacrocolpopexy is regarded as the reference standard treatment for apical compartment prolapse and multicompartment prolapse. In most
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women with moderate to severe pelvic organ prolapse, bladder and bowel dysfunction improves after sacrocolpopexy (2-4). However, de novo bowel or bladder dysfunction can occur (2, 5) .
Traditionally, the procedure has been performed as an open procedure. However, there is strong evidence that sacrocolpopexy can be performed successfully either laparoscopically or robotically assisted (4, 6) . One advantage of the minimally invasive approach is that fine structures such as vessels and nerves can be visualized and magnified with surgical loupes glasses.
The inferior hypogastric nerve (IHN) is important for maintaining bladder, bowel and sexual function. The nerve originates at the level of the sacrum and runs down the pelvis to the genital organs and bladder. The posterior part of the IHN supplies the rectum and the anterior part the genital organs. At the level of the sacrouterine ligaments, the nerve bundles are situated medial to the vessels, in the deep peritoneum. However, the IHN and its fine fibers are difficult to identify, resulting in iatrogenic lesions, which are often ignored and commonly tolerated, although this can lead to bladder, bowel and sexual dysfunction. To date, there are sparse data regarding how successfully the IHN is preserved during sacrocolpopexy, so avoiding bladder, bowel and sexual dysfunction (7) (8) (9) .
This study was performed to assess the outcome regarding bowel and bladder function (improvement and de novo dysfunction) after nerve-sparing sacrocolpopexy (NS-SCP).
Material and methods

Patients
From February 2014 until March 2016, all women undergoing a laparoscopic sacrocolpopexy with or without concomitant subtotal or total hysterectomy for apical or multicompartment prolapse stage II or greater were included in this prospective cohort study. The exclusion criteria were conversion to an open abdominal sacrocolpopexy and being unable to return for evaluation. The study was performed at the Department of Urogynecology, Cantonal Hospital of Lucerne, Switzerland (tertiary referral hospital).
Assessments
The patients' full gynecologic history was taken and recorded. To assess the subjective symptoms, all women completed the validated German Female Pelvic Floor Questionnaire, which contains bladder, bowel, prolapse and sexual function domains, preoperatively and postoperatively. The higher the score, the more bothersome are the symptoms (10, 11) . The bladder function domain contains questions regarding stress urinary incontinence (SUI), overactive bladder symptoms (OAB) with and without urge incontinence, voiding difficulties and elevated postvoid residual volume (PVR). The bowel function domain contains questions regarding constipation, laxative use, stool-outlet obstruction including digital evacuation and fecal incontinence.
To assess preoperative and postoperative fecal incontinence, the Wexner-score was used (12) . The questionnaire consists of five domains of fecal incontinence, i.e. solid, liquid, gas, wears pads, lifestyle alteration. Higher Wexner-scores represent more severe symptoms or greater distress. All these symptoms were assessed preoperatively and postoperatively.
In all women, comprehensive multichannel urodynamic studies were performed preoperatively, in order to objectify the symptoms. The urodynamic studies included a conventional filling-cystometry (with maximal bladder filling up to 500 mL) and a pressure-flow study according to the recommendations of the International Continence Society (ICS) (13) . The PVR was measured after bladder voiding using catheterization. A clinical cough stress test was performed in all women to assess SUI with and without prolapse reduction at a minimum of 300 mL bladder filling. An additional pad-weigh-test (1-h short form) was performed according to ICS recommendation (13) . This test was only used in women who reported SUI or OAB with urge incontinence on history but with a negative initial cough test to guide the severity of incontinence. This test was only performed in four women. A repeat cough test was then performed and demonstrated in the second run clear SUI. Finally, a cystoscopy was performed to exclude any so far undetected bladder pathologies. The objective results were recorded as SUI, OAB with or without urinary incontinence, voiding dysfunction, current urinary tract infections or painful bladder syndrome (multiple diagnoses were possible). Overactive bladder with or without urinary incontinence and voiding dysfunction were defined according to the standardized terminology of the International Urogynecological Association and ICS (14) . The occurrence of recurrent urinary tract infection preoperatively was determined based on the medical history, a current urine culture and postoperatively based urine cultures.
To assess the degree of pelvic organ prolapse, the Pelvic Organ Prolapse Quantification system (POP Q) was performed according to the ICS preoperatively and postoperatively at 6-12 weeks (15). The objective success was defined as follows: stage <I for the apex as well as the anterior and posterior compartment, POP-Q point C <À4 and <À1 for points Aa and Ap. Furthermore, women were asked whether the pre-existing bladder and bowel dysfunctions have resolved, improved or deteriorated and if any change in medication or de novo bladder and bowel dysfunction have occurred.
Laparoscopic sacrocolpopexy
A nerve-sparing approach was used. At the level of the sacral promontory, the peritoneum was opened carefully, and the longitudinal ligament was dissected after identification and under continuous visualization of the IHN medial to the ligament. The middle sacral veins represented the end of the medial dissection. Further superficial opening of the peritoneum from the sacral promontory to the vaginal apex along the right pelvic sidewall was performed. Deep dissection was avoided, especially at the remnant uterosacral ligament, to preserve the IHN. The branches of the IHN can be visualized as seen in Figure 1 .
The vesicovaginal space was opened and dissected down to the bladder neck. Laterally the vessels of the vesicouterine ligaments present the lateral border of the dissection plan as the bladder branches of the IHN run along the deep portion of the vesicouterine ligaments. The rectovaginal space was then opened and carefully dissected along the vaginal probe to the cranial edge of the perineal body at the level of the levator ani muscle. The peritoneal tunnel was joint with dissection of the superficial layer of the right uterosacral ligament, preserving its deep nervous portion as described by Ercoli et al. (8) .The fixation of the polypropylene mesh anteriorly, posteriorly and at the sacral promontory was conducted in the usual manner under visualization of the IHN medial to the points of fixation (16) .
Statistical analyses
The median and the lower and upper quartiles of the range as well as proportions and 95% CI using the Clopper-Pearson exact binomial method were calculated.
The differences in the proportions between the timepoints were tested using Fisher's exact test. The Wilcoxon signed-rank test was used to investigate the differences between the time-points. The statistical analyses were performed using the R software environment version 3.4.0, Copyright 2017 (The R Foundation for Statistical Computing). A p-value of ≤0.05 was considered significant.
Ethical approval
The study was approved by the Local Ethics Committee (EKNZ 01676).
Results
During the study period of 36 months, a total of 137 women were included and evaluated. Two women were unable to present for the follow-up visit due to being too fragile to travel. Two additional women returned only for objective assessment postoperatively, not for subjective outcome assessment. However, no woman was excluded from this study. There was no conversion from a minimal invasive approach to an open sacrocolpopexy. Table 1 summarizes the demographics, previous pelvic floor surgery and surgery performed concomitantly at the time of NS-SCP. A minority of women had concurrent vaginal repair (22/137, 16%) or anti-incontinence surgery (13/137, 9%). Significant objective improvement for POP-Q points Aa, Ap and C (p < 0.0001) preoperatively to postoperatively was seen, as shown in Table 2 . Table 3 shows the bladder function data preoperatively and 6-12 weeks postoperatively. There was a significant (p < 0.001) improvement in bladder function (presence of OAB, SUI, elevated PVR), postoperatively. Persisting symptomatic OAB was seen in 23.9% (16/67), persisting elevated PVR in 7.7% (3/39) and persisting need for clean intermittent self-catheterization (CISC) in 0% of the investigated women. In 72%, the OAB symptoms resolved and anti-muscarinic medication was ceased.
All women (n = 3) with postoperatively persisting PVR showed detrusor underactivity on urodynamic investigation preoperatively. All women were successfully treated with a a 1 -adrenergic receptor antagonist. Two women showed de novo elevated PVR with the indication of CISC. There was one woman with persisting voiding dysfunction with the de novo CISC, post operatively. De novo OAB and SUI were seen in 2.3% (3/133) and 6.8% (9/133) of the investigated women, respectively. Both women with de novo bladder outlet obstruction and elevated PVR had an NS-SCP with concomitant midurethral sling insertion. In both cases, bladder function returned to normal with persisting SUI after release of the tapes. Both women were treated successfully with a second sling after a 3-month interval. The number of women with urinary tract infection decreased significantly (p < 0.001) from 24/137 (17.5%) to 5/133 (3.8%). Table 4 summarizes the bowel function data preoperatively and 6-12 weeks postoperatively. There was a significant (p < 0.006) improvement in bowel function (presence of bowel incontinence, constipation and digital evacuation), postoperatively. Of the women with preoperative fecal incontinence symptoms, 76.5% (13/17) improved postoperatively. No de novo fecal incontinence occurred. Resolution of pre-existing obstipation occurred in 73.5% (25/34) and de novo constipation was seen in 5.8% (6/103) of the investigated women.
The data of the German Female Pelvic Floor Questionnaire are summarized in Table 5 . All women showed a significant (p < 0.001) improvement in all four domains of the questionnaire including a sub-analysis of the dyspareunia rate.
Discussion
This study demonstrates clearly that the overall functional symptoms improve significantly and de novo bladder and de novo bowel dysfunction can be minimized when a laparoscopic sacrocolpopexy is performed under the aspect of a nerve-sparing approach.
To date there are only two video publications available on NS-SCP. The exact surgical techniques and steps are clearly described (7, 8) . Experienced surgeons easily implement the surgical steps during the dissection of the perineum, and the vesicovaginal and rectovaginal spaces. Both studies reported no functional outcomes. Our surgical techniques are in line with Ercoli et al. by preserving the INH at the level of the sacral promontory and the remnant uterosacral ligaments and by respecting the borders of the dissection plane anteriorly and posteriorly down to the level of the perineal body (8) . To date there are no data available on functional outcomes regarding bladder dysfunction after NS-SCP.
Most large randomized controlled trials or prospective studies on standard sacrocolpopexy report sparsely on de novo bladder dysfunction. Only a few crude figures are available on de novo OAB, bladder outlet obstruction or elevated PVR with CISC (5). Most studies emphasize their analysis of postoperatively persisting or de novo SUI. Data on overall postoperative functional findings or resolution of functional outcome measurements are, however, reported (3, 6, (17) (18) (19) . De novo OAB and voiding difficulties are less assessed compared with de novo SUI. (9) . Their small comparative study, with 25 women in the NS-SCP group compared with 18 women in the standard sacrocolpopexy group, showed no de novo bowel dysfunction based on subjective outcome measures in the NS-SCP group. Furthermore, no difference was observed regarding de novo obstipation. In their review of the literature on sacrocolpopexy, functional outcomes and mesh placement, they concluded that the placement of the mesh posteriorly at the level of the levator ani muscle might be an explanation for the increased bowel dysfunction rate in those studies. That would support our data with low de novo bowel dysfunction as we place the mesh posteriorly at the level of the perineal body, according to Cosma et al. (9) . In our study, we observed a low de novo constipation rate of 5.3% and a significant decrease in the constipation rate of over 50% (p < 0.004). The highest reported resolution rate of constipation after standard sacrocolpopexy ranges from 16 to 30% (7, 18, 20) , whereas one large study found no difference between preoperative and postoperative constipation rates after sacrocolpopexy (17) . In most women with moderate to severe POP, bowel dysfunction resolved due to surgery. In the CARE-trial at the one-year and five-year follow up, a 71-80% reduction of bothersome bowel symptoms, an 8% reduction in de novo incomplete evacuation and a 5% reduction in de novo straining was reported (2,21). Lewis et al. demonstrated similar findings for obstructive bowel symptoms with significant improvements (22) . Our findings on improvements of bowel dysfunction and de novo dysfunction are superior to the findings reported in the literature.
One limitation of our study is that it is not of a randomized nature. However, a randomized controlled trial comparing NS-SCP vs. standard sacrocolpopexy would be difficult to conduct. Furthermore, the study was performed in a single center, and long-term follow ups are missing.
Conclusion
However, our data from a large cohort of 137 consecutive women undergoing NS-SCP demonstrated clearly that functional outcomes seems to be better compared with data reported in the common literature. We therefore encourage pelvic surgeons to maintain the IHN when performing pelvic organ prolapse surgery to avoid bladder, bowel and sexual dysfunction.
